NRF1 and breast carcinoma: Stable NRF1 overexpressing MCF10A cells, after treatment with a carcinogenic regimen of E2, were grown as mammospheres in B27 medium then flow cell sorted for the breast cancer stem cell signature CD24−/CD44+.